Biotec Pharmacon ASA (BIOTEC):企業財務及び戦略的SWOT分析

◆英語タイトル:Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム


Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and marine enzymes. The company’s products are used in the areas of human medicine such as immunotherapy of cancer, general infection prophylaxis, and imbalanced immune responses, among others. It offers research and development (R&D) of marine gene products for molecular biology sector and beta and glucan formulations within the pharmaceutical sector. Biotec Pharmacon carries out cellular or molecular level research on its proprietary beta-1,3/1,6-glucan products, a non-toxic modulator that improves immune resistance. The company operates through two subsidiaries, namely, Biotec BetaGlucans AS and ArcticZymes AS. Biotec Pharmacon is headquartered in Tromso, Norway.

Biotec Pharmacon ASA Key Recent Developments

Oct 25, 2016: Biotec Pharmacon: Q3 2016 Results
Oct 24, 2016: First homecare customer in Germany
Sep 30, 2016: ArcticZymes launches its first Polymerase product and has been granted patent protection on its heat-labile Salt Active Nuclease in the USA
Aug 17, 2016: Biotec Pharmacon: Q2 2016 Results
Jun 13, 2016: Biotec cleared in arbitration matter

This comprehensive SWOT profile of Biotec Pharmacon ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biotec Pharmacon ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Biotec Pharmacon ASA – Key Information
Biotec Pharmacon ASA – Overview
Biotec Pharmacon ASA – Key Employees
Biotec Pharmacon ASA – Key Employee Biographies
Biotec Pharmacon ASA – Key Operational Heads
Biotec Pharmacon ASA – Major Products and Services
Biotec Pharmacon ASA – History
Biotec Pharmacon ASA – Company Statement
Biotec Pharmacon ASA – Locations And Subsidiaries
Biotec Pharmacon ASA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Biotec Pharmacon ASA – Business Description
Biotec Pharmacon ASA – Corporate Strategy
Biotec Pharmacon ASA – SWOT Analysis
SWOT Analysis – Overview
Biotec Pharmacon ASA – Strengths
Biotec Pharmacon ASA – Weaknesses
Biotec Pharmacon ASA – Opportunities
Biotec Pharmacon ASA – Threats
Biotec Pharmacon ASA – Key Competitors

Section 3 – Company Financial Performance Charts

Biotec Pharmacon ASA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Biotec Pharmacon ASA, Key Information
Biotec Pharmacon ASA, Key Ratios
Biotec Pharmacon ASA, Share Data
Biotec Pharmacon ASA, Major Products and Services
Biotec Pharmacon ASA, History
Biotec Pharmacon ASA, Key Employees
Biotec Pharmacon ASA, Key Employee Biographies
Biotec Pharmacon ASA, Key Operational Heads
Biotec Pharmacon ASA, Other Locations
Biotec Pharmacon ASA, Subsidiaries
Biotec Pharmacon ASA, Key Manufacturing facilities
Biotec Pharmacon ASA, Key Competitors
Biotec Pharmacon ASA, SWOT Analysis
Biotec Pharmacon ASA, Ratios based on current share price
Biotec Pharmacon ASA, Annual Ratios
Biotec Pharmacon ASA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Biotec Pharmacon ASA, Performance Chart
Biotec Pharmacon ASA, Ratio Charts


★リサーチレポート[ Biotec Pharmacon ASA (BIOTEC):企業財務及び戦略的SWOT分析(Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。